SMTL ID : 8x0y.1 (1 other biounit)

Crystal structure of JM-1A in complex with SARS-CoV-2 RBD

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.94 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-FUC.1: 5 residues within 4Å: Chain A: F.6, G.7, N.11, V.35, L.36 No protein-ligand interaction detected (PLIP)

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 2 residues within 4Å: Chain A: R.23, F.132 Ligand excluded by PLIP

1 x PO4: PHOSPHATE ION(Non-functional Binders)

PO4.3: 0 residues within 4Å: (No contacts) No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chen, X. et al., The presence of broadly neutralizing anti-SARS-CoV-2 RBD antibodies elicited by primary series and booster dose of COVID-19 vaccine. Plos Pathog. (2024)

Release Date

2024-06-05

Peptides

Spike protein S1: A
Heavy chain of JM-1A Fab: B
Light chain of JM-1A Fab: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

B
E

C
F

Spike protein S1

Heavy chain of JM-1A Fab

Light chain of JM-1A Fab

Related Entries With Identical Sequence